Monteverde & Associates PC Recovers Money for Shareholders in Alimera Sciences, Inc. Merger Investigation
Monteverde & Associates PC, a renowned class action firm headquartered at the Empire State Building in New York City, has recently recovered money for shareholders and has been recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. The firm is currently investigating Alimera Sciences, Inc. (Nasdaq: ALIM) in relation to its proposed merger with ANI Pharmaceuticals, Inc.
Under the terms of the agreement, Alimera Sciences shareholders are set to receive $5.50 per share, along with one contingent value right that could potentially yield an additional $0.50 per share based on certain net revenue targets in 2026 and 2027.
For more information on this investigation, interested parties can visit the firm’s website at https://monteverdelaw.com/case/alimera-sciences-inc/. The firm emphasizes that there is no cost or obligation to obtain additional information.
Monteverde & Associates PC prides itself on its successful track record in trial and appellate courts, including the U.S. Supreme Court. The firm is dedicated to ensuring that no company, director, or officer is above the law, and is committed to advocating for the rights of shareholders.
Individuals who own common stock in Alimera Sciences, Inc. or any other listed companies and have concerns or seek additional information can visit the firm’s website or contact Juan Monteverde, Esq. via email at [email protected] or by telephone at (212) 971-1341.
Attorney Advertising. (C) 2024